To Compare the efficacy of Transamic acid (TA) injection vs Hydroquinone, Flucinolone acetonide and Tretinoin for melasma
Phase 3
Recruiting
- Conditions
- Melasma.
- Registration Number
- IRCT20210823052264N1
- Lead Sponsor
- PNS SHIFA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Males and females 18-55 years with facial melasma
Exclusion Criteria
Patients who has bleeding disorders, pregnant women and lactating mothers.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The degree of melasma treatment. Timepoint: Before treatment, at 4th, 8th and 12th week during the treatment. Method of measurement: MASI Score.
- Secondary Outcome Measures
Name Time Method